WAM
MRNA icon

Warberg Asset Management’s Moderna MRNA Stock Holding History

Warberg Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,000
Closed -$267K – 228
2024
Q3 		$267K Hold
4,000
– – 0.07% 111
2024
Q2 		$475K Hold
4,000
– – 0.13% 90
2024
Q1 		$426K Sell
4,000
-2,000
-33% -$202K 0.1% 82
2023
Q4 		$597K Sell
6,000
-8,000
-57% -$673K 0.18% 71
2023
Q3 		$1.45M Buy
14,000
+8,000
+133% +$892K 0.45% 41
2023
Q2 		$729K Buy
+6,000
New +$800K 0.21% 54
2022
Q1 		– Sell
-1,600
Closed -$406K – 260
2021
Q4 		$406K Sell
1,600
-7,400
-82% -$2.16M 0.12% 83
2021
Q3 		$3.46M Buy
+9,000
New +$3.32M 1% 32

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return